News | August 5, 2015

New App Helps Consumers Find More Ways to Save on Prescription Drugs OneRx® is the First App to Provide Instant Access to Co-pays, Coupons and Discounts to Reduce Patients’ Rx Costs NEW YORK – WEDNESDAY, AUGUST 5, 2015 – As prescription prices and...

News | July 28, 2015

FDA Approves The ReShape™ Integrated Dual Balloon System, a First-Of-Its-Kind Non-Surgical Weight Loss Procedure for People with Mild to Moderate Obesity – Next generation dual balloon designed to create a feeling of fullness while providing patient comfort and...

Portfolio News | October 27, 2005

NxStage Medical, Inc. Sets Price For Initial Public Offering Lawrence, MA – October 27, 2005 : NxStage Medical, Inc. today announced the initial public offering of 5,500,000 shares of its common stock at a price of $10.00 per share, before underwriting discounts and...

Portfolio News | May 19, 2006

Quest Diagnostics to Acquire Focus Diagnostics, Inc., A World Leader in Infectious Disease Testing LYNDHURST, N.J., and HERNDON, Va., May 19 /PRNewswire-FirstCall/ — Quest Diagnostics Incorporated (NYSE: DGX), the nation’s leading provider of diagnostic...

Portfolio News | August 2, 2006

Cerexa Reports Positive Top-Line Results for Phase 2 Clinical Trial of Ceftaroline Broad-Spectrum Anti-Infective Achieves Excellent Clinical, Microbiological Cure Rates for cSSSI Compared to Standard Therapy ALAMEDA, Calif., Aug. 2, 2006 — Cerexa Inc. today...